LivWell Infusions, a Scottsdale, Arizona-based provider of outpatient infusion and injection therapy for patients with complex chronic conditions, received an investment from Frontline Healthcare Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to accelerate growth across the Southwest and nationally.
Founded in 2020 and Ernesto Garza, CEO, LivWell administers infusions and injections for patients suffering from compromised immune systems, infectious disease, and other medical conditions. The company currently provides infusion services to patients across allergy/immunology, cardiology, gastroenterology, oncology, ophthalmology, neurology, and rheumatology. LivWell operates ambulatory infusion centers and infusions practice management, including services to physician offices such as insurance benefit verifications, prior authorizations, inventory procurement, amongst others. Today, the company offers convenient, patient-first therapy across Arizona, California, New Mexico, Indiana and Pennsylvania.
FinSMEs
21/08/2022